KIMBERLY CLARK CORP (Form: 10-Q, Received: 07/25/2016 11:07:38)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2016

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

Commission file number 1-225

KIMBERLY-CLARK CORPORATION

( Exact name of registrant as specified in its charter)



Delaware		39-0394230
(State or other jurisdiction of incorporation)		(I.R.S. Employer Identification No.)

P. O. Box 619100

Dallas, Texas

75261-9100

(Address of principal executive offices)

(Zip code)

(972) 281-1200

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.



Large accelerated filer	x	Accelerated filer	o
Non-accelerated filer	o (Do not check if a smaller reporting company)	Smaller reporting company	o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

As of July 18, 2016 , there were 359,636,074 shares of the Corporation's common stock outstanding.

Table of Contents



PART I – FINANCIAL INFORMATION	3

Item 1. Financial Statements	3

UNAUDITED CONSOLIDATED INCOME STATEMENT FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2016 AND 2015	3
UNAUDITED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2016 AND 2015	4
CONSOLIDATED BALANCE SHEET AS OF JUNE 30, 2016 (UNAUDITED) AND DECEMBER 31, 2015	5
UNAUDITED CONSOLIDATED CASH FLOW STATEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2016 AND 2015	6
UNAUDITED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS	7

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	15

Item 4. Controls and Procedures	22

PART II – OTHER INFORMATION	23

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	23

Item 6. Exhibits	24

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES

CONSOLIDATED INCOME STATEMENT

(Unaudited)



	Three Months Ended June 30						Six Months Ended June 30
(Millions of dollars, except per share amounts)	2016			2015			2016			2015
Net Sales	$	4,588		$	4,643		$	9,064		$	9,334
Cost of products sold	2,924			2,986			5,761			6,018
Gross Profit	1,664			1,657			3,303			3,316
Marketing, research and general expenses	847			869			1,672			1,718
Other (income) and expense, net	(21		)	1,332			(11		)	1,394
Operating Profit (Loss)	838			(544		)	1,642			204
Interest income	3			4			7			8
Interest expense	(81		)	(73		)	(157		)	(145		)
Income (Loss) Before Income Taxes and Equity Interests	760			(613		)	1,492			67
Provision for income taxes	(217		)	281			(424		)	51
Income (Loss) Before Equity Interests	543			(332		)	1,068			118
Share of net income of equity companies	35			39			70			75
Net Income (Loss)	578			(293		)	1,138			193
Net income attributable to noncontrolling interests	(12		)	(12		)	(27		)	(30		)
Net Income (Loss) Attributable to Kimberly-Clark Corporation	$	566		$	(305	)	$	1,111		$	163

Per Share Basis
Net Income (Loss) Attributable to Kimberly-Clark Corporation
Basic	$	1.57		$	(0.84	)	$	3.08		$	0.45
Diluted	$	1.56		$	(0.83	)	$	3.06		$	0.44

Cash Dividends Declared	$	0.92		$	0.88		$	1.84		$	1.76

See Notes to Consolidated Financial Statements.

KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

(Unaudited)



	Three Months Ended June 30						Six Months Ended June 30
(Millions of dollars)	2016			2015			2016			2015
Net Income (Loss)	$	578		$	(293	)	$	1,138		$	193
Other Comprehensive Income (Loss), Net of Tax
Unrealized currency translation adjustments	(72		)	152			136			(316		)
Employee postretirement benefits	13			853			7			861
Other	12			(25		)	(7		)	(5		)
Total Other Comprehensive Income (Loss), Net of Tax	(47		)	980			136			540
Comprehensive Income	531			687			1,274			733
Comprehensive income attributable to noncontrolling interests	(9		)	(10		)	(31		)	(25		)
Comprehensive Income Attributable to Kimberly-Clark Corporation	$	522		$	677		$	1,243		$	708

See Notes to Consolidated Financial Statements.

KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEET

(2016 Data is Unaudited)



(Millions of dollars)	June 30, 2016		December 31, 2015
ASSETS
Current Assets
Cash and cash equivalents	$	656	$	619
Accounts receivable, net	2,249		2,281
Inventories	1,807		1,909
Other current assets	402		617
Total Current Assets	5,114		5,426
Property, Plant and Equipment, Net	7,188		7,104
Investments in Equity Companies	287		247
Goodwill	1,507		1,446
Other Assets	674		619
TOTAL ASSETS	$	14,770	$	14,842

LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Debt payable within one year	$	772	$	1,669
Trade accounts payable	2,448		2,612
Accrued expenses	1,677		1,750
Dividends payable	331		318
Total Current Liabilities	5,228		6,349
Long-Term Debt	6,905		6,106
Noncurrent Employee Benefits	1,192		1,137
Deferred Income Taxes	626		766
Other Liabilities	331		380
Redeemable Preferred Securities of Subsidiaries	64		64
Stockholders' Equity (Deficit)
Kimberly-Clark Corporation	196		(174		)
Noncontrolling Interests	228		214
Total Stockholders' Equity	424		40
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	14,770	$	14,842

See Notes to Consolidated Financial Statements.

KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES

CONSOLIDATED CASH FLOW STATEMENT

(Unaudited)



	Six Months Ended June 30
(Millions of dollars)	2016			2015
Operating Activities
Net income	$	1,138		$	193
Depreciation and amortization	349			383
Stock-based compensation	45			51
Deferred income taxes	3			(346		)
Equity companies' earnings (in excess of) less than dividends paid	(30		)	(37		)
(Increase) decrease in operating working capital	(48		)	(417		)
Postretirement benefits	(4		)	908
Adjustments related to Venezuelan operations	(11		)	45
Other	(29		)	12
Cash Provided by Operations	1,413			792
Investing Activities
Capital spending	(397		)	(527		)
Proceeds from sales of investments	28			—
Investments in time deposits	(73		)	(82		)
Maturities of time deposits	42			91
Other	16			(8		)
Cash Used for Investing	(384		)	(526		)
Financing Activities
Cash dividends paid	(650		)	(631		)
Change in short-term debt	(322		)	183
Debt proceeds	796			510
Debt repayments	(591		)	(44		)
Proceeds from exercise of stock options	58			82
Acquisitions of common stock for the treasury	(293		)	(358		)
Shares purchased from noncontrolling interest	—			(151		)
Other	(1		)	5
Cash Used for Financing	(1,003		)	(404		)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	11			(48		)
Increase (Decrease) in Cash and Cash Equivalents	37			(186		)
Cash and Cash Equivalents - Beginning of Period	619			789
Cash and Cash Equivalents - End of Period	$	656		$	603

See Notes to Consolidated Financial Statements.

KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 . Accounting Policies

Basis of Presentation

The accompanying unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all material adjustments which are of a normal and recurring nature necessary for a fair presentation of the results for the periods presented have been reflected. Dollar amounts are reported in millions, except per share dollar amounts, unless otherwise noted.

For further information, refer to the Consolidated Financial Statements and footnotes included in our Annual Report on Form 10‑K for the year ended December 31, 2015 . The terms "Corporation," "Kimberly-Clark," "K-C," "we," "our" and "us" refer to Kimberly-Clark Corporation and its consolidated subsidiaries.

Accounting for Venezuelan Operations

Effective December 31, 2015, we deconsolidated the assets and liabilities of our business in Venezuela from our consolidated balance sheet and moved to the cost method of accounting for our operations in that country. As of the first quarter of 2016, we no longer include the results of our Venezuelan business in our consolidated financial statements. The change resulted in the recognition of an after tax charge of $102 in the fourth quarter of 2015 and, for the three months ended June 30, 2016, other income of $11 related to an updated assessment. In addition, for the three months ended March 31, 2015, we recorded a non-deductible charge of $45 related to a balance sheet remeasurement. Net sales of K‑C Venezuela were insignificant in 2015.

Balance Sheet Classification of Deferred Taxes

In 2015, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") No. 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes . Under this ASU, a reporting entity is required to classify all deferred tax assets and liabilities as noncurrent in a classified balance sheet. Current guidance requiring the offsetting of deferred tax assets and liabilities of a tax-paying component of an entity and presentation as a single noncurrent amount is not affected. We early adopted this ASU prospectively as of March 31, 2016 and our consolidated balance sheet reflects the new guidance for classification of deferred taxes. Prior periods were not recasted.

New Accounting Standards

In 2016, the FASB issued ASU No. 2016-09, Compensation-Stock Compensation (Topic 718) . The new guidance simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. For public companies, the amendments in this standard are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption is permitted. The effects of this standard on our financial position, results of operations and cash flows are not expected to be material.

In 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) . Under the new guidance, a lessee will be required to recognize assets and liabilities for all leases with lease terms of more than 12 months. Consistent with current GAAP, the recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee primarily will depend on its classification as a finance or operating lease. The ASU requires additional disclosures. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The ASU requires adoption based upon a modified retrospective transition approach. Early adoption is permitted. The effects of this standard on our financial position, results of operations and cash flows are not yet known.

In 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers , which provides a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and will supersede most current revenue recognition guidance. In 2016, the FASB issued four amendments to the ASU. The standard is effective for public companies for annual and interim periods beginning after December 15, 2017. Early adoption is permitted as of one year prior to the current effective date. The guidance permits two implementation approaches, one requiring retrospective application of the new standard with restatement of prior years and one requiring prospective application of the new standard with disclosure of results under old standards. The effects of this standard on our financial position, results of operations and cash flows are not expected to be material.

Note 2 . 2014 Organization Restructuring

Total pretax charges were $1 ( $1 after tax) and $12 ( $8 after tax) for the three months ended June 30, 2016 and 2015 , respectively. Total pretax charges were $15 ( $11 after tax) and $25 ( $13 after tax) for the six months ended June 30, 2016 and 2015 , respectively. Through June 30, 2016 , cumulative pretax charges for the restructuring were $211 ( $148 after tax). Cash payments during the six months ended June 30, 2016 and 2015 related to the restructuring were $40 and $49 , respectively.

Note 3 . Fair Value Information

The following fair value information is based on a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The three levels in the hierarchy used to measure fair value are:

Level 1 – Unadjusted quoted prices in active markets accessible at the reporting date for identical assets and liabilities.

Level 2 – Quoted prices for similar assets or liabilities in active markets. Quoted prices for identical or similar assets and liabilities in markets that are not considered active or financial instruments for which all significant inputs are observable, either directly or indirectly.

Level 3 – Prices or valuations that require inputs that are significant to the valuation and are unobservable.

A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. During the six months ended June 30, 2016 and for the full year 2015 , there were no significant transfers among level 1, 2, or 3 fair value determinations.

Company-owned life insurance ("COLI") assets and derivative assets and liabilities are measured on a recurring basis at fair value. COLI assets were $58 and $57 at June 30, 2016 and December 31, 2015 . The COLI policies are a source of funding primarily for our nonqualified employee benefits and are included in other assets. The fair value amount of the COLI policies is measured at fair value using the net asset value per share practical expedient, and therefore, is not classified in the fair value hierarchy.

At June 30, 2016 and December 31, 2015 , derivative assets were $51 and $56 , respectively, and derivative liabilities were $41 and $42 , respectively. The fair values of derivatives used to manage interest rate risk and commodity price risk are based on LIBOR rates and interest rate swap curves and NYMEX price quotations, respectively. The fair value of hedging instruments used to manage foreign currency risk is based on published quotations of spot currency rates and forward points, which are converted into implied forward currency rates. Measurement of our derivative assets and liabilities is considered a level 2 measurement. Additional information on our classification and use of derivative instruments is contained in Note 7 .

Redeemable preferred securities of subsidiaries are measured on a recurring basis at fair value and were $64 at both June 30, 2016 and December 31, 2015 . They are not traded in active markets. For certain redeemable securities, fair values were calculated using a floating rate pricing model that compared the stated spread to the fair value spread to determine the price at which each of the financial instruments should trade. The model used the following inputs to calculate fair values: face value, current LIBOR rate, unobservable fair value credit spread, stated spread, maturity date and interest or dividend payment dates. The fair value of the remaining redeemable securities was based on various inputs, including an independent third-party appraisal, adjusted for current market conditions. Measurement of the redeemable preferred securities is considered a level 3 measurement.

The following table includes the fair value of our financial instruments for which disclosure of fair value is required:



	Fair Value Hierarchy Level	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
	Fair Value Hierarchy Level	June 30, 2016				December 31, 2015
Assets
Cash and cash equivalents ^(a)	1	$	656	$	656	$	619	$	619
Time deposits and other ^(b)	1	148		148		124		124
Liabilities and redeemable securities of subsidiaries
Short-term debt ^(c)	2	758		758		1,071		1,071
Long-term debt ^(d)	2	6,919		7,862		6,704		7,300


(a)	Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value.

(b)

Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in other current assets or other assets in the Consolidated Balance Sheet, as appropriate. Other, included in other current assets, is composed of funds held in escrow. Time deposits and other are recorded at cost, which approximates fair value.


(c)	Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.


(d)	Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.

Note 4 . Employee Postretirement Benefits

The table below presents net periodic benefit cost information for defined benefit plans and other postretirement benefit plans:



	Pension Benefits						Other Benefits
	Three Months Ended June 30
	2016			2015			2016			2015
Service cost	$	10		$	9		$	3		$	2
Interest cost	37			45			9			9
Expected return on plan assets	(40		)	(55		)	—			—
Recognized net actuarial loss	13			19			(1		)	(1		)
Settlements	—			1,320			—			—
Other	(2		)	(2		)	—			—
Net periodic benefit cost	$	18		$	1,336		$	11		$	10



	Pension Benefits						Other Benefits
	Six Months Ended June 30
	2016			2015			2016			2015
Service cost	$	24		$	19		$	6		$	6
Interest cost	75			109			17			17
Expected return on plan assets	(81		)	(130		)	—			—
Recognized net actuarial loss	26			48			(1		)	(1		)
Settlements	—			1,329			—			—
Other	(5		)	(7		)	—			—
Net periodic benefit cost	$	39		$	1,368		$	22		$	22

Effective January 2015, the U.S. pension plan was amended to include a lump-sum pension benefit payout option for certain plan participants. In addition, in April 2015, the U.S. pension plan completed the purchase of group annuity contracts that transferred to two insurance companies the pension benefit obligations totaling $2.5 billion for approximately 21,000 Kimberly-Clark retirees in the United States. As a result of these changes, we recognized pension settlement-related charges of $0.8 billion after tax ( $1.4 billion pretax in other (income) and expense, net) during 2015, mostly in the second quarter. In connection with these transactions, during the first quarter of 2015 we made a $410 contribution to our U.S. pension plan in order to maintain the plan’s funded status.

For the six months ended June 30, 2016 and 2015 , we made cash contributions of $30 and $435 , respectively, to our pension trusts. We expect to contribute up to $100 to our defined benefit pension plans for the full year 2016.

Note 5 . Earnings Per Share ("EPS")

There are no adjustments required to be made to net income for purposes of computing EPS. A reconciliation of the average number of common shares outstanding used in the basic and diluted EPS computations follows:



	Three Months Ended June 30		Six Months Ended June 30
(Millions of shares)	2016	2015	2016	2015
Basic	360.0	364.3	360.4	364.7
Dilutive effect of stock options and restricted share unit awards	2.4	2.4	2.5	2.6
Diluted	362.4	366.7	362.9	367.3

Options outstanding that were not included in the computation of diluted EPS because their exercise price was greater than the average market price of the common shares were insignificant.

The number of common shares outstanding as of June 30, 2016 and 2015 was 359.7 million and 364.3 million , respectively.

Note 6 . Stockholders' Equity (Deficit)

Set forth below is a reconciliation for the six months ended June 30, 2016 of the carrying amount of total stockholders' equity (deficit) from the beginning of the period to the end of the period.



	Stockholders' Equity (Deficit) Attributable to
	The Corporation			Noncontrolling Interests
Balance at December 31, 2015	$	(174	)	$	214
Net Income	1,111			26
Other comprehensive income, net of tax
Unrealized translation	132			4
Employee postretirement benefits	7			—
Other	(7		)	—
Stock-based awards exercised or vested	58			—
Recognition of stock-based compensation	45			—
Income tax benefits on stock-based compensation	15			—
Shares repurchased	(327		)	—
Dividends declared	(663		)	(16		)
Other	(1		)	—
Balance at June 30, 2016	$	196		$	228

During the six months ended June 30, 2016 , we repurchased 2.3 million shares at a total cost of $300 pursuant to a share repurchase program authorized by our Board of Directors.

Net unrealized currency gains or losses resulting from the translation of assets and liabilities of foreign subsidiaries, except those in highly inflationary economies, are recorded in accumulated other comprehensive income ("AOCI"). For these operations, changes in exchange rates generally do not affect cash flows; therefore, unrealized translation is recorded in AOCI rather than net income. Upon sale or substantially complete liquidation of any of these subsidiaries, the applicable unrealized translation would be removed from AOCI and reported as part of the gain or loss on the sale or liquidation.

Also included in unrealized translation are the effects of foreign exchange rate changes on intercompany balances of a long-term investment nature and transactions designated as hedges of net foreign investments.

The change in net unrealized currency translation for the six months ended June 30, 2016 was primarily due to the strengthening of most foreign currencies versus the U.S. dollar, including the Brazilian real, Australian dollar, Russian ruble, South Korean won and the Canadian dollar, partially offset by the weakening of the British pound sterling.

The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows:



	Unrealized Translation			Defined Benefit Pension Plans				Other Postretirement Benefit Plans			Cash Flow Hedges and Other
Balance as of December 31, 2014	$	(1,335	)	$	(1,924	)		$	(37	)	$	(16	)
Other comprehensive income (loss) before reclassifications	(310		)	9				7			16
(Income) loss reclassified from AOCI	—			844			(a)	—			(21		)
Net current period other comprehensive income (loss)	(310		)	853				7			(5		)
Shares purchased from noncontrolling interest and other	(12		)	—				—			1
Balance as of June 30, 2015	$	(1,657	)	$	(1,071	)		$	(30	)	$	(20	)

Balance as of December 31, 2015	$	(2,252	)	$	(1,013	)		$	(3	)	$	(10	)
Other comprehensive income (loss) before reclassifications	132			2				(9		)	6
(Income) loss reclassified from AOCI	—			14			(a)	—			(13		)
Net current period other comprehensive income (loss)	132			16				(9		)	(7		)
Balance as of June 30, 2016	$	(2,120	)	$	(997	)		$	(12	)	$	(17	)


(a)	Included in computation of net periodic pension costs (see Note 4 ).

During the first quarter of 2015 , we acquired the remaining 49.9 percent interest in our subsidiary in Israel, Hogla-Kimberly, Ltd., for $151 . As our subsidiary in Turkey was wholly-owned by our subsidiary in Israel, through this acquisition we also effectively acquired the remaining 49.9 percent interest in our subsidiary in Turkey, Kimberly-Clark Tuketim Mallari Sanayi ve Ticaret A.s.

The purchase of additional ownership in an already controlled subsidiary is treated as an equity transaction with no gain or loss recognized in consolidated net income or comprehensive income. The effect of the change in ownership interest is as follows:



	Six Months Ended June 30, 2015
Net income attributable to Kimberly-Clark Corporation	$	163
Decrease in Kimberly-Clark Corporation's additional paid-in capital for acquisition	(94		)
Change from net income attribution to Kimberly-Clark Corporation and transfers to noncontrolling interests	$	69

Note 7 . Objectives and Strategies for Using Derivatives

As a multinational enterprise, we are exposed to financial risks, such as changes in foreign currency exchange rates, interest rates, and commodity prices. We employ a number of practices to manage these risks, including operating and financing activities and, where appropriate, the use of derivative instruments. We enter into derivative instruments to hedge a portion of forecasted cash flows denominated in foreign currencies for non-U.S. operations' purchases of raw materials, which are priced in U.S. dollars, and imports of intercompany finished goods and work-in-process priced predominantly in U.S. dollars and euros. The derivative instruments used to manage these exposures are designated and qualify as cash flow hedges. The foreign currency exposure on certain non-functional currency denominated monetary assets and liabilities, primarily intercompany loans and accounts payable, is hedged with primarily undesignated derivative instruments.

Interest rate risk is managed using a portfolio of variable- and fixed-rate debt composed of short- and long-term instruments. Interest rate swap contracts may be used to facilitate the maintenance of the desired ratio of variable- and fixed-rate debt and are designated and qualify as fair value hedges. From time to time, we also hedge the anticipated issuance of fixed-rate debt, using forward-starting swaps, and these contracts are designated as cash flow hedges.

We use derivative instruments, such as forward swap contracts, to hedge a limited portion of our exposure to market risk arising from changes in prices of certain commodities. These derivatives are designated as cash flow hedges of specific quantities of the underlying commodity expected to be purchased in future months.

Translation adjustments result from translating foreign entities' financial statements into U.S. dollars from their functional currencies. The risk to any particular entity's net assets is reduced to the extent that the entity is financed with local currency borrowing. Translation exposure, which results from changes in translation rates between functional currencies and the U.S. dollar,

generally is not hedged. However, consistent with other years, a portion of our net investment in our Mexican affiliate has been hedged. At June 30, 2016 , we had in place net investment hedges of $89 for a portion of our investment in our Mexican affiliate.

Set forth below is a summary of the designated and undesignated fair values of our derivative instruments:



	Assets				Liabilities
	June 30, 2016		December 31, 2015		June 30, 2016		December 31, 2015
Foreign currency exchange contracts	$	42	$	56	$	35	$	27
Interest rate contracts	7		—		—		—
Commodity price contracts	2		—		6		15
Total	$	51	$	56	$	41	$	42

The derivative assets are included in the Consolidated Balance Sheet in other current assets and other assets, as appropriate. The derivative liabilities are included in the Consolidated Balance Sheet in accrued expenses and other liabilities, as appropriate.

Derivative instruments that are designated and qualify as fair value hedges are predominantly used to manage interest rate risk. The fair values of these derivative instruments are recorded as an asset or liability, as appropriate, with the offset recorded in current earnings. The offset to the change in fair values of the related hedged items also is recorded in current earnings. Any realized gain or loss on the derivatives that hedge interest rate risk is amortized to interest expense over the life of the related debt. At June 30, 2016 , the aggregate notional values of outstanding interest rate contracts designated as fair value hedges were $375 . Fair value hedges resulted in no significant ineffectiveness in the six months ended June 30, 2016 and 2015 . For the six months ended June 30, 2016 and 2015, gains or losses recognized in interest expense for interest rate swaps were not significant. For the six month periods ended June 30, 2016 and 2015 , no gain or loss was recognized in earnings as a result of a hedged firm commitment no longer qualifying as a fair value hedge.

For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative instrument is initially recorded in AOCI, net of related income taxes, and recognized in earnings in the same period that the hedged exposure affects earnings. As of June 30, 2016 , outstanding commodity forward contracts were in place to hedge a limited portion of our estimated requirements of the related underlying commodities in the remainder of 2016 and future periods. As of June 30, 2016 , the aggregate notional value of outstanding foreign exchange derivative contracts designated as cash flow hedges was $795 , and there were no outstanding interest rate derivative contracts designated as cash flow hedges. Cash flow hedges resulted in no significant ineffectiveness for the six months ended June 30, 2016 and 2015 . For the six months ended June 30, 2016 and 2015 , no gains or losses were reclassified into earnings as a result of the discontinuance of cash flow hedges due to the original forecasted transaction no longer being probable of occurring. At June 30, 2016 , amounts to be reclassified from AOCI during the next twelve months are not expected to be material. The maximum maturity of cash flow hedges in place at June 30, 2016 is December 2018 .

Gains or losses on undesignated foreign exchange hedging instruments are immediately recognized in other (income) and expense, net. A loss of $14 and a gain of $74 were recorded in the three months ended June 30, 2016 and 2015 , respectively. A gain of $14 and a loss of $81 were recorded in the six months ended June 30, 2016 and 2015 , respectively. The effect on earnings from the use of these non-designated derivatives is substantially neutralized by the transactional gains and losses recorded on the underlying assets and liabilities. At June 30, 2016 , the notional amount of these undesignated derivative instruments was $2 billion .

Note 8 . Business Segment Information

We are organized into operating segments based on product groupings. These operating segments have been aggregated into three reportable global business segments: Personal Care, Consumer Tissue and K-C Professional. The reportable segments were determined in accordance with how our executive managers develop and execute global strategies to drive growth and profitability. These strategies include global plans for branding and product positioning, technology, research and development programs, cost reductions including supply chain management, and capacity and capital investments for each of these businesses. Segment management is evaluated on several factors, including operating profit. Segment operating profit excludes other (income) and expense, net and income and expense not associated with the business segments.

The principal sources of revenue in each global business segment are described below:

•

Personal Care brands offer our consumers a trusted partner in caring for themselves and their families by delivering confidence, protection and discretion through a wide variety of innovative solutions and products such as disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, and other related products. Products in this segment are sold under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Kotex, U by Kotex, Intimus, Depend, Plenitud, Poise and other brand names.


•	Consumer Tissue offers a wide variety of innovative solutions and trusted brands that touch and improve people's lives every day. Products in this segment include facial and bathroom tissue, paper towels, napkins and related products, and are sold under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve and other brand names.

•

K-C Professional partners with businesses to create Exceptional Workplaces, helping to make them healthier, safer and more productive through a range of solutions and supporting products such as wipers, tissue, towels, apparel, soaps and sanitizers. Our brands, including Kleenex, Scott, WypAll, Kimtech and Jackson Safety, are well-known for quality and trusted to help people around the world work better.

The following schedules present information concerning consolidated operations by business segment:



	Three Months Ended June 30								Six Months Ended June 30
	2016			2015			Change		2016			2015			Change
NET SALES
Personal Care	$	2,279		$	2,306		-1.2	%	$	4,486		$	4,614		-2.8	%
Consumer Tissue	1,494			1,499			-0.3	%	2,990			3,073			-2.7	%
K-C Professional	806			822			-1.9	%	1,569			1,617			-3.0	%
Corporate & Other	9			16			N.M.		19			30			N.M.
TOTAL NET SALES	$	4,588		$	4,643		-1.2	%	$	9,064		$	9,334		-2.9	%

OPERATING PROFIT
Personal Care	$	455		$	473		-3.8	%	$	904		$	928		-2.6	%
Consumer Tissue	275			260			+5.8	%	555			551			+0.7	%
K-C Professional	150			145			+3.4	%	300			279			+7.5	%
Corporate & Other	(63		)	(90		)	N.M.		(128		)	(160		)	N.M.
Other (income) and expense, net ^(a)	(21		)	1,332			N.M.		(11		)	1,394			N.M.
TOTAL OPERATING PROFIT (LOSS)	$	838		$	(544	)	N.M.		$	1,642		$	204		N.M.

N.M. - Not Meaningful


(a)	Other (income) and expense, net includes charges related to pension settlements of $1,322 and $1,331 for the three and six months ended June 30, 2015 , respectively. See Note 4 for additional information.

Note 9 . Supplemental Balance Sheet Data

The following schedule presents a summary of inventories by major class:



	June 30, 2016								December 31, 2015
(Summary of Inventories by Major Class)	LIFO			Non-LIFO		Total			LIFO			Non-LIFO		Total
Raw materials	$	94		$	265	$	359		$	100		$	297	$	397
Work in process	106			97		203			110			93		203
Finished goods	472			659		1,131			525			689		1,214
Supplies and other	—			281		281			—			278		278
	672			1,302		1,974			735			1,357		2,092
Excess of FIFO or weighted-average cost over LIFO cost	(167		)	—		(167		)	(183		)	—		(183		)
Total	$	505		$	1,302	$	1,807		$	552		$	1,357	$	1,909

Inventories are valued at the lower of cost and net realizable value, determined on the FIFO or weighted-average cost methods, and at the lower of cost or market, determined on the LIFO cost method.

The following schedule presents a summary of property, plant and equipment, net:



	June 30, 2016			December 31, 2015
Land	$	166		$	164
Buildings	2,609			2,537
Machinery and equipment	13,621			13,393
Construction in progress	393			453
	16,789			16,547
Less accumulated depreciation	(9,601		)	(9,443		)
Total	$	7,188		$	7,104


Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations

Introduction

This management's discussion and analysis of financial condition and results of operations is intended to provide investors with an understanding of our recent performance, financial condition and prospects. The following will be discussed and analyzed:


•	Overview of Second Quarter 2016 Results


•	Results of Operations and Related Information


•	Liquidity and Capital Resources


•	Legal Matters


•	Business Outlook

We describe our business outside North America in two groups – Developing and Emerging Markets ("D&E") and Developed Markets. D&E markets comprise Eastern Europe, the Middle East and Africa, Latin America and Asia-Pacific, excluding Australia and South Korea. Developed Markets consist of Western and Central Europe, Australia and South Korea.

Throughout this MD&A, we refer to financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S., or GAAP, and are therefore referred to as non-GAAP financial measures. These measures include adjusted operating profit, adjusted net income, adjusted earnings per share, adjusted other (income) and expense, net, and adjusted effective tax rate. We believe these measures provide our investors with additional information about our underlying results and trends, as well as insight to some of the financial measures used to evaluate management.

Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the comparable GAAP measures, and they should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP. There are limitations to these non-GAAP financial measures because they are not prepared in accordance with GAAP and may not be comparable to similarly titled measures of other companies due to potential differences in methods of calculation and items being excluded. We compensate for these limitations by using these non-GAAP financial measures as a supplement to the GAAP measures and by providing reconciliations of the non-GAAP and comparable GAAP financial measures.

The non-GAAP financial measures exclude the following items for the relevant time periods as indicated in the reconciliations included later in this MD&A:


•	2014 Organization Restructuring - In 2014, we initiated a restructuring plan in order to improve organization efficiency and offset the impact of stranded overhead costs resulting from the spin-off of our health care business. Results in both 2016 and 2015 include charges related to this initiative. See additional information in Note 2 of the consolidated financial statements.


•	Adjustments related to Venezuelan Operations - In 2016 and 2015, we recorded adjustments related to our Venezuelan operations. See additional information in Note 1 of the consolidated financial statements.


•	Pension settlement charges - In 2015, we recorded settlement-related charges from certain actions taken for our U.S. pension plan. See additional information in Note 4 of the consolidated financial statements.

Overview of Second Quarter 2016 Results


•	Net sales of $4.6 billion decreased 1 percent compared to the prior year, as changes in foreign currency exchange rates reduced net sales by 4 percent. Organic sales increased 3 percent, including a 7 percent volume increase in North American personal care and consumer tissue and a 5 percent increase in organic sales in developing and emerging markets.


•	Operating profit of $838 improved compared to an operating loss of $544 in 2015. Net income attributable to Kimberly-Clark Corporation was $566 in 2016 compared to a loss of $305 in the prior year. Diluted earnings per share were $1.56 in 2016 versus the prior year $0.83 loss. Results in 2015 included $1,322 of pretax pension settlement-related charges.

Results of Operations and Related Information

This section presents a discussion and analysis of our second quarter 2016 net sales, operating profit and other information relevant to an understanding of the results of operations. Our analysis of the results for the three month and six month periods ended June 30, 2016 reflects comparison to the same three and six month periods ended June 30, 2015. In addition, we provide commentary regarding organic sales growth, which describes the impact of changes in volume, product mix and net selling price on net sales. Changes in foreign currency rates also impact the year-over-year change in net sales.

Consolidated



Selected Financial Results	Three Months Ended June 30								Six Months Ended June 30
	2016			2015			Percent Change		2016			2015		Percent Change
Net Sales	$	4,588		$	4,643		-1.2	%	$	9,064		$	9,334	-2.9	%
Other (income) and expense, net	(21		)	1,332			N.M.		(11		)	1,394		N.M.
Operating Profit (Loss)	838			(544		)	N.M.		1,642			204		N.M.
Provision for income taxes	(217		)	281			N.M.		(424		)	51		N.M.
Share of net income of equity companies	35			39			-10.3	%	70			75		-6.7	%
Net Income (Loss)	578			(293		)	N.M.		1,138			193		N.M.
Net Income (Loss) Attributable to Kimberly-Clark Corporation	566			(305		)	N.M.		1,111			163		N.M.
Diluted Earnings (Loss) per Share	1.56			(0.83		)	N.M.		3.06			0.44		N.M.

Operating Profit (Loss) Reconciliation of GAAP to Non-GAAP

Operating Profit (Loss) includes the following adjusting items:



	Three Months Ended June 30						Six Months Ended June 30
	2016			2015			2016			2015
Operating Profit (Loss), GAAP	$	838		$	(544	)	$	1,642		$	204
Plus adjustments for:
2014 Organization Restructuring	1			12			15			25
Pension Settlements	—			1,322			—			1,331
Adjustments Related to Venezuelan Operations	(11		)	—			(11		)	45
Adjusted Operating Profit	$	828		$	790		$	1,646		$	1,605

Analysis of Consolidated Net Sales and Operating Profit



Net Sales	Percent Change				Adjusted Operating Profit	Percent Change
	Three Months Ended June 30		Six Months Ended June 30			Three Months Ended June 30		Six Months Ended June 30
Volume	4		3		Volume	11		8
Net Price	—		—		Net Price	(2	)	—
Mix/Other ^(a)	(1	)	(1	)	Input Costs	3		3
Currency	(4	)	(5	)	Cost Savings	12		12
Total	(1.2	)	(2.9	)	Currency Translation	(3	)	(5	)
^(a) Includes rounding					Other ^(b)	(16	)	(15	)
^(b) Includes the impact of changes in marketing, research, and general expenses, foreign currency transaction effects and other manufacturing costs					Total	4.8		2.6

Net sales of $4.6 billion in the second quarter of 2016 decreased 1 percent compared to prior year. Changes in foreign currency exchange rates reduced net sales 4 percent. Organic sales increased 3 percent, as sales volumes increased 4 percent, while changes in product mix/other decreased net sales by 1 percent.

Second quarter operating profit was $838 in 2016 and a loss of $544 in 2015. Results in 2015 included $1,322 of pension settlement-related charges. Adjusted operating profit of $828 in the second quarter of 2016 increased 5 percent compared to $790 in the prior year. The increase included benefits from organic sales growth, $95 in cost savings from the company’s FORCE (Focused On Reducing Costs Everywhere) program and $15 of savings from the 2014 Organization Restructuring. Input costs decreased $20, mostly due to lower fiber costs. Translation effects due to changes in foreign currency exchange rates lowered operating profit by $25 and transaction effects also negatively impacted the comparison.

Net sales for the first six months of 2016 of $9.1 billion decreased 3 percent compared to prior year, as changes in foreign currency exchange rates reduced net sales by more than 5 percent. Organic sales increased approximately 3 percent due to higher sales volumes.

Year-to-date operating profit was $1,642 in 2016 compared to $204 in 2015. Results in 2015 included $1,331 of pension settlement-related charges. Adjusted operating profit of $1,646 in 2016 increased 3 percent compared to $1,605 in 2015. Results in 2016 included $190 of FORCE cost savings and $30 of savings from the 2014 Organization Restructuring. In addition, input costs were $50 lower. Translation effects due to changes in foreign currency exchange rates lowered operating profit by $75 and transaction effects also negatively impacted results.

Other (Income) and Expense, Net Reconciliation of GAAP to Non-GAAP

Other (income) and expense, net includes the following adjusting items:



	Three Months Ended June 30					Six Months Ended June 30
	2016			2015		2016			2015
Other (income) and expense, net, GAAP	$	(21	)	$	1,332	$	(11	)	$	1,394
Less adjustments for:
Pension Settlements	—			1,322		—			1,331
Adjustments Related to Venezuelan Operations	(11		)	—		(11		)	40
Adjusted other (income) and expense, net	$	(10	)	$	10	$	—		$	23

Adjusted other (income) and expense, net was impacted in all periods by foreign currency transaction gains and losses.

Provision for Income Taxes Reconciliation of GAAP to Non-GAAP

Provision for income taxes includes the following adjusting items:



	Three Months Ended June 30						Six Months Ended June 30
	2016			2015			2016			2015
Effective Tax Rate, GAAP	28.6		%	45.8		%	28.4		%	N.M.
(Provision) Benefit for income taxes, GAAP	$	(217	)	$	281		$	(424	)	$	51
Plus adjustments for:
2014 Organization Restructuring	—			4			4			12
Pension Settlements	—			509			—			512
Adjusted (Provision) Benefit for income taxes	$	(217	)	$	(232	)	$	(428	)	$	(473	)
Adjusted Effective Tax Rate	28.9		%	32.2		%	28.6		%	32.2		%

The decrease in the adjusted effective tax rate for the three and six month periods ended June 30, 2016 is due to resolution of certain tax matters. In addition, the adjusted effective tax rate for the six month period ended June 30, 2016 included benefits from certain tax planning initiatives.

Share of Net Income of Equity Companies

Our share of net income of equity companies was $35 and $39 for the three months ended June 30, 2016 and 2015 , respectively, and $70 and $75 for the six months ended June 30, 2016 and 2015 , respectively. Kimberly-Clark de Mexico, S.A.B. de C.V. results were impacted by a weaker Mexican peso, mostly offset by benefits from organic sales growth, lower input costs and cost savings.

Net Income (Loss) Attributable to Kimberly-Clark and Diluted Earnings Per Share

Reconciliations of GAAP to Non-GAAP

Net Income (Loss) Attributable to Kimberly-Clark and Diluted Earnings Per Share include the following adjusting items:



	Three Months Ended June 30						Six Months Ended June 30
	2016			2015			2016			2015
Net Income (Loss) Attributable to Kimberly-Clark, GAAP	$	566		$	(305	)	$	1,111		$	163
Plus adjustments (net of tax) for:
2014 Organization Restructuring	1			8			11			13
Pension Settlements	—			813			—			819
Adjustments Related to Venezuelan Operations	(11		)	—			(11		)	45
Adjusted Net Income Attributable to Kimberly-Clark	$	556		$	516		$	1,111		$	1,040



	Three Months Ended June 30						Six Months Ended June 30
	2016			2015			2016			2015
Diluted Earnings (Loss) Per Share, GAAP	$	1.56		$	(0.83	)	$	3.06		$	0.44
Plus adjustments for:
2014 Organization Restructuring	—			0.02			0.03			0.04
Pension Settlements	—			2.22			—			2.23
Adjustments Related to Venezuelan Operations	(0.03		)	—			(0.03		)	0.12
Adjusted Earnings Per Share	$	1.53		$	1.41		$	3.06		$	2.83

The increase in adjusted earnings per share for the three and six months ended June 30, 2016 is primarily due to benefits from organic sales growth, cost savings and a lower effective tax rate.

Results By Geography



	Three Months Ended June 30						Six Months Ended June 30
	2016			2015			2016			2015
NET SALES
North America	$	2,410		$	2,359		$	4,783		$	4,719
Outside North America	2,254			2,370			4,429			4,788
Intergeographic sales	(76		)	(86		)	(148		)	(173		)
TOTAL NET SALES	$	4,588		$	4,643		$	9,064		$	9,334

OPERATING PROFIT (LOSS)
North America	$	589		$	532		$	1,159		$	1,060
Outside North America	291			346			600			698
Corporate & Other	(63		)	(90		)	(128		)	(160		)
Other (income) and expense, net ^(a)	(21		)	1,332			(11		)	1,394
TOTAL OPERATING PROFIT (LOSS)	$	838		$	(544	)	$	1,642		$	204


^(a)	Corporate & Other and Other (income) and expense, net include expenses not associated with the business segments, including charges as indicated in the Non-GAAP Reconciliations.

Results by Business Segments

Personal Care



	Three Months Ended June 30					Six Months Ended June 30						Three Months Ended June 30					Six Months Ended June 30
	2016		2015			2016		2015				2016		2015			2016		2015
Net Sales	$	2,279	$	2,306		$	4,486	$	4,614		Operating Profit	$	455	$	473		$	904	$	928

Net Sales	Percent Change					Percent Change					Operating Profit	Percent Change					Percent Change
Volume			6					5			Volume			15					11
Net Price			(1		)			(1		)	Net Price			(7		)			(4		)
Mix/Other ^(a)			—					—			Input Costs			2					4
Currency			(6		)			(7		)	Cost Savings			12					13
Total			(1.2		)			(2.8		)	Currency Translation			(4		)			(6		)
^(a) Includes rounding											Other ^(b)			(22		)			(21		)
^(b) Includes the impact of changes in marketing, research, and general expenses, foreign currency transaction effects and other manufacturing costs											Total			(3.8		)			(2.6		)

Second quarter net sales of $2.3 billion decreased 1 percent compared to prior year. Unfavorable currency rates reduced net sales 6 percent. Sales volumes increased 6 percent while changes in net selling prices decreased net sales by 1 percent. Second quarter operating profit of $455 decreased 4 percent. The comparison was impacted by unfavorable currency effects and increased marketing, research and general spending on a local currency basis, partially offset by organic sales growth and cost savings.

Net sales in North America increased 4 percent. Sales volumes increased 8 percent. Changes in net selling prices decreased net sales by 3 percent, including increased promotion activity to support product innovations, and changes in product mix decreased net sales by 1 percent. Adult care, child care and feminine care volumes each increased approximately 10 percent and diaper volumes increased mid-single digits. Overall volumes benefited from innovations, market share improvements and promotion activity, along with category growth in adult care.

Net sales in developing and emerging markets decreased 7 percent, including a 13 percent impact from unfavorable currency rates. Sales volumes increased 6 percent and changes in net selling prices increased net sales by 1 percent, while changes in product mix decreased net sales by 1 percent. The sales volume growth included gains in Brazil, China, Eastern Europe and South Africa. The higher net selling prices were driven by Latin America in response to weaker currency rates and local cost inflation, mostly offset by declines in China due to increased promotion activity.

Net sales in developed markets outside North America decreased 2 percent, including a 4 percent unfavorable impact from currency rates. Sales volumes increased 4 percent, driven by Australia, while changes in net selling prices decreased net sales by 2 percent.

Consumer Tissue



	Three Months Ended June 30					Six Months Ended June 30						Three Months Ended June 30					Six Months Ended June 30
	2016		2015			2016		2015				2016		2015			2016		2015
Net Sales	$	1,494	$	1,499		$	2,990	$	3,073		Operating Profit	$	275	$	260		$	555	$	551

Net Sales	Percent Change					Percent Change					Operating Profit	Percent Change					Percent Change
Volume			3					1			Volume			9					4
Net Price			—					—			Net Price			2					3
Mix/Other ^(a)			(1		)			—			Input Costs			4					2
Currency			(2		)			(4		)	Cost Savings			7					6
Total			(0.3		)			(2.7		)	Currency Translation			(1		)			(2		)
^(a) Includes rounding											Other ^(b)			(15		)			(12		)
^(b) Includes the impact of changes in marketing, research, and general expenses, foreign currency transaction effects and other manufacturing costs											Total			5.8					0.7

Second quarter net sales of $1.5 billion were essentially even with the prior year. Sales volumes increased 3 percent, while currency had an unfavorable impact of 2 percent and changes in product mix decreased net sales by 1 percent. Second quarter operating profit of $275 increased 6 percent. The comparison benefited from organic sales growth, cost savings and input cost deflation, partially offset by unfavorable currencies.

Net sales in North America increased 4 percent. Sales volumes increased 6 percent, with mid-to-high single-digit increases in all product categories, led by facial tissue. Changes in product mix decreased net sales by 2 percent.

Net sales in developing and emerging markets decreased 8 percent, including a 9 percent impact from unfavorable currency rates. Changes in net selling prices increased net sales by 3 percent and changes in product mix increased net sales by 1 percent, while sales volumes decreased about 4 percent. The changes in net selling prices and volumes mostly occurred in Latin America.

Net sales in developed markets outside North America decreased 2 percent. Currency rates were unfavorable 2 percent. The combined impact of changes in net selling prices and product mix reduced net sales approximately 2 percent, while volumes improved 1 percent.

K-C Professional



	Three Months Ended June 30					Six Months Ended June 30						Three Months Ended June 30					Six Months Ended June 30
	2016		2015			2016		2015				2016		2015			2016		2015
Net Sales	$	806	$	822		$	1,569	$	1,617		Operating Profit	$	150	$	145		$	300	$	279

Net Sales	Percent Change					Percent Change					Operating Profit	Percent Change					Percent Change
Volume			(1		)			—			Volume			(1		)			3
Net Price			1					1			Net Price			8					6
Mix/Other ^(a)			—					—			Input Costs			1					1
Currency			(2		)			(4		)	Cost Savings			13					11
Total			(1.9		)			(3.0		)	Currency Translation			(2		)			(3		)
^(a) Includes rounding											Other ^(b)			(16		)			(10		)
^(b) Includes the impact of changes in marketing, research, and general expenses, foreign currency transaction effects and other manufacturing costs											Total			3.4					7.5

Second quarter net sales of $0.8 billion decreased 2 percent. Unfavorable changes in currency rates reduced net sales 2 percent. Changes in net selling prices increased net sales by 1 percent, while sales volumes decreased 1 percent. Changes in product mix/other was even year-on-year despite an approximate 1 percent impact from lower sales of nonwovens to Halyard Health, Inc. Second quarter operating profit of $150 increased 3 percent. The comparison benefited from cost savings, mostly offset by unfavorable currency effects.

Net sales in North America increased 1 percent. The combined impact of changes in net selling prices and product mix increased net sales 2 percent, while volumes decreased 1 percent.

Net sales in developing and emerging markets decreased 4 percent, including a 10 percent impact from unfavorable currency rates. Changes in net selling prices and product mix increased net sales by 5 percent and 1 percent, respectively.

Net sales in developed markets outside North America decreased 2 percent. Changes in currency rates reduced net sales 1 percent and the combined impact of changes in net selling prices and product mix lowered net sales by 1 percent.

2014 Organization Restructuring

In 2014, we initiated a restructuring plan in order to improve organization efficiency and offset the impact of stranded overhead costs resulting from the spin-off of our health care business. The restructuring is intended to improve underlying profitability and increase our flexibility to invest in targeted growth initiatives, brand building and other capabilities critical to delivering future growth. The plan is expected to be completed by the end of 2016, with total costs, primarily severance, anticipated to be toward the high end of the range of $130 to $160 after tax ( $190 to $230 pretax). Cash costs are projected to be approximately 80 percent of the total charges. Cumulative pretax savings from the restructuring are expected to be toward the high end of the range of $120 to $140 by the end of 2017, and were $100 through June 30, 2016 . The restructuring is expected to impact all of our business segments and our organizations in all major geographies. Total pretax charges were $1 ( $1 after tax) and $12 ( $8 after tax) for the three months ended June 30, 2016 and 2015 , respectively. Total pretax charges were $15 ( $11 after tax) and $25 ( $13 after tax) for the six months ended June 30, 2016 and 2015 , respectively.

Defined Benefit Pension Plan Changes

Liquidity and Capital Resources

Cash Provided by Operations

Cash provided by operations was $1.4 billion for the first six months of 2016 , compared to $0.8 billion in the prior year. The increase included benefits from higher cash earnings, improved working capital and lower pension contributions. For the six months ended June 30, 2016 and 2015 defined benefit pension plan contributions were $30 and $435, respectively.

Investing

During the first six months of 2016 , our capital spending was $397 compared to $527 in the prior year. We anticipate that full-year 2016 capital spending will be between $950 and $1,050.

Financing

On February 22, 2016, we issued $400 aggregate principal amount of 1.40% notes due February 15, 2019 and $400 aggregate principal amount of 2.75% notes due February 15, 2026. Proceeds from the offering were used for general corporate purposes, including repayment of a portion of our outstanding commercial paper indebtedness.

Our short-term debt, which consists of U.S. commercial paper with original maturities up to 90 days and/or other similar short-term debt issued by non-U.S. subsidiaries, was $758 as of June 30, 2016 (included in debt payable within one year on the Consolidated Balance Sheet). The average month-end balance of short-term debt for the second quarter of 2016 was $692 . These short-term borrowings provide supplemental funding for supporting our operations. The level of short-term debt generally fluctuates depending upon the amount of operating cash flows and the timing of customer receipts and payments for items such as pension contributions, dividends and income taxes.

At June 30, 2016 , total debt was $7.7 billion compared to $7.8 billion at December 31, 2015 .

We maintain a $2.0 billion revolving credit facility which expires in 2019. This facility, currently unused, supports our commercial paper program, and would provide liquidity in the event our access to the commercial paper markets is unavailable for any reason.

We repurchase shares of Kimberly-Clark common stock from time to time pursuant to publicly announced share repurchase programs. During the first six months of 2016 , we repurchased 2.3 million shares of our common stock at a cost of $300 through a broker in the open market. We are targeting full-year 2016 share repurchases of $700 to $800, subject to market conditions.

Business Outlook

In 2016, we plan to continue to execute our Global Business Plan strategies, which include a focus on targeted growth initiatives, innovation and brand building, cost savings programs and shareholder-friendly capital allocation. In 2016, we expect diluted earnings per share in a range of $5.92 to $6.15 and adjusted earnings per share in a range of $5.95 to $6.15. The adjusted earnings per share excludes expected 2014 Organization Restructuring charges equivalent to $0.03 to $0.06 and the positive impact of an

adjustment related to Venezuela recorded in the second quarter equivalent to $0.03. Our adjusted earnings per share guidance is based on the assumptions described below:


•	Growth in organic sales is expected to be at the low end of the previously assumed range of 3 to 5 percent range. This reflects lower expected benefits from selling price increases, primarily due to an improved currency outlook.


•	We expect negative foreign currency translation effects on net sales and operating profit to be 4 to 5 percent (prior assumption toward the low end of the 5 to 6 percent range). Currency transaction effects are also anticipated to negatively impact operating profit.


•	We anticipate the net impact of changes in commodity costs to be between $25 and $125 of deflation year-on-year.


•	We plan to achieve cost savings of $350 to $400 from our FORCE program (previous assumption at least $350), and at least $50 from the 2014 Organization Restructuring.


•	We anticipate that advertising spending will be similar to, or up slightly, as a percentage of net sales to support targeted growth initiatives, brand building and innovation activities.


•	We expect the full-year 2016 effective tax rate and adjusted effective tax rate to be in the lower half of the 30.5 to 32.5 percent target range.


•	Our share of net income from equity companies is expected to be similar to, or down somewhat, compared to 2015.

Information Concerning Forward-Looking Statements

Certain matters contained in this report concerning the business outlook, including the anticipated costs, scope, timing and financial and other effects of the 2014 Organization Restructuring, the anticipated cost savings from the company’s FORCE program, cash flow and uses of cash, growth initiatives, innovations, marketing and other spending, cost savings and reductions, net sales, anticipated currency rates and exchange risks, raw material, energy and other input costs, contingencies and anticipated transactions of Kimberly-Clark, including dividends, share repurchases and pension contributions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and are based upon management's expectations and beliefs concerning future events impacting Kimberly-Clark. There can be no assurance that these future events will occur as anticipated or that our results will be as estimated. Forward-looking statements speak only as of the date they were made, and we undertake no obligation to publicly update them.

The assumptions used as a basis for the forward-looking statements include many estimates that, among other things, depend on the achievement of future cost savings and projected volume increases. In addition, many factors outside our control, including fluctuations in foreign currency exchange rates, the prices and availability of our raw materials, potential competitive pressures on selling prices for our products, energy costs and retail trade customer actions, as well as general economic and political conditions globally and in the markets in which we do business, could affect the realization of these estimates.

For a description of certain factors that could cause our future results to differ from those expressed in these forward-looking statements, see Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2015 entitled "Risk Factors." Other factors not presently known to us or that we presently consider immaterial could also affect our business operations and financial results.


Item 4.	Controls and Procedures

As of June 30, 2016 , an evaluation was performed under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on that evaluation, management, including the Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were effective as of June 30, 2016 . There were no changes in our internal control over financial reporting during the quarter covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

We repurchase shares of Kimberly-Clark common stock from time to time pursuant to publicly announced share repurchase programs. All our share repurchases during the second quarter of 2016 were made through a broker in the open market.

The following table contains information for shares repurchased during the second quarter of 2016 . None of the shares in this table were repurchased directly from any of our officers or directors.



Period (2016)	Total Number of Shares Purchased ^(a)	Average Price Paid Per Share	Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number of Shares That May Yet Be Purchased Under the Plans or Programs
April 1 to April 30	375,000	$132.93	5,251,811	34,748,189
May 1 to May 31	380,000	127.61	5,631,811	34,368,189
June 1 to June 30	392,000	131.48	6,023,811	33,976,189
Total	1,147,000


(a)	Share repurchases were made pursuant to a share repurchase program authorized by our Board of Directors on November 13, 2014. This program allows for the repurchase of 40 million shares in an amount not to exceed $5 billion.

Item 6. Exhibits


(a)	Exhibits

Exhibit No. (3)a. Amended and Restated Certificate of Incorporation, dated April 30, 2009, incorporated by reference to Exhibit No. (3)a of the Corporation's Current Report on Form 8-K dated May 1, 2009.

Exhibit No. (3)b. By-Laws, as amended December 14, 2015, incorporated by reference to Exhibit No. (3)b of the Corporation's Current Report on Form 8-K dated December 14, 2015.

Exhibit No. (4). Copies of instruments defining the rights of holders of long-term debt will be furnished to the Securities and Exchange Commission on request.

Exhibit No. (10)l. 2011 Outside Directors' Compensation Plan, as amended and restated, effective May 4, 2016, filed herewith.

Exhibit No. (10)n. Form of Award Agreements under 2011 Equity Participation Plan for Nonqualified Stock Options filed herewith.

Exhibit No. (10)r. Form of Award Agreement under 2011 Equity Participation Plan for Time-Vested Restricted Stock Units, filed herewith.

Exhibit No. (31)a. Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), filed herewith.

Exhibit No. (31)b. Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act, filed herewith.

Exhibit No. (32)a. Certification of Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code, furnished herewith.

Exhibit No. (32)b. Certification of Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code, furnished herewith.

Exhibit No. (101).INS XBRL Instance Document

Exhibit No. (101).SCH XBRL Taxonomy Extension Schema Document

Exhibit No. (101).CAL XBRL Taxonomy Extension Calculation Linkbase Document

Exhibit No. (101).DEF XBRL Taxonomy Extension Definition Linkbase Document

Exhibit No. (101).LAB XBRL Taxonomy Extension Label Linkbase Document

Exhibit No. (101).PRE XBRL Taxonomy Extension Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.




KIMBERLY-CLARK CORPORATION
(Registrant)

By:		/s/ Maria Henry
		Maria Henry
		Senior Vice President and
		Chief Financial Officer
		(principal financial officer)

By:		/s/ Michael T. Azbell
		Michael T. Azbell
		Vice President and Controller
		(principal accounting officer)

July 25, 2016

EXHIBIT INDEX




Exhibit No.		Description

(3)a.		Amended and Restated Certificate of Incorporation, dated April 30, 2009, incorporated by reference to Exhibit No. (3)a of the Corporation's Current Report on Form 8-K dated May 1, 2009.

(3)b.		By-Laws, as amended December 14, 2015, incorporated by reference to Exhibit No. (3)b of the Corporation's Current Report on Form 8-K dated December 14, 2015.

(4).		Copies of instruments defining the rights of holders of long-term debt will be furnished to the Securities and Exchange Commission on request.

(10)l.		2011 Outside Directors' Compensation Plan, as amended and restated, effective May 4, 2016, filed herewith.

(10)n.		Exhibit No. (10)n. Form of Award Agreement under 2011 Equity Participation Plan for Nonqualified Stock Options, filed herewith.

(10)r.		Exhibit No. (10)r. Form of Award Agreement under 2011 Equity Participation Plan for Time-Vested Restricted Stock Units, filed herewith.

(31)a.		Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), filed herewith.

(31)b.		Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act, filed herewith.

(32)a.		Certification of Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code, furnished herewith.

(32)b.		Certification of Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code, furnished herewith.

(101).INS		XBRL Instance Document

(101).SCH		XBRL Taxonomy Extension Schema Document

(101).CAL		XBRL Taxonomy Extension Calculation Linkbase Document

(101).DEF		XBRL Taxonomy Extension Definition Linkbase Document

(101).LAB		XBRL Taxonomy Extension Label Linkbase Document

(101).PRE		XBRL Taxonomy Extension Presentation Linkbase Document


3.	Nontransferability . Except as may otherwise be provided by the Committee, this option shall be transferable only by will or by the laws of descent and distribution, and during the Participant's lifetime shall be exercisable only by him or her.


14.	Successors . This Award Agreement, including but not limited to the non-competition obligations described in Section 16 below, shall be binding upon and inure to the benefit of any successor or successors of the Corporation.


15.	Defined Terms . Terms which are capitalized are defined herein or in the Plan and have the same meaning set forth in the Plan, unless the context indicates otherwise.


•	Unless otherwise agreed with the Corporation, the option and shares of Common Stock covered by the option, and the income and value of same, are not granted as consideration for, or in connection with, any service I may provide as a director of any Affiliate.


•	The future value of the underlying shares is unknown, indeterminable, and cannot be predicted with certainty. If the underlying shares do not increase in value, the option will have no value. If I exercise this option and obtain shares, the value of those shares acquired upon exercise may increase or decrease in value, even below the option price.


•	Neither the Corporation, the Employer nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between my local currency and the United States Dollar that may affect the value of this option or of any amounts due to me pursuant to the exercise of this option or the subsequent sale of any shares of Common Stock acquired upon exercise.


(1)	withholding from my wages or other cash compensation paid to me by the Corporation and/or the Employer; or


(2)	withholding from the proceeds of the sale of shares acquired pursuant to the exercise of this option, either through a voluntary sale or through a mandatory sale arranged by the Corporation (on my behalf, pursuant to this authorization); or


(3)	withholding shares to be issued upon exercise of this option.


•	The Corporation is not providing any tax, legal or financial advice, nor is the Corporation making any recommendations regarding my participation in the Plan, or my acquisition or sale of the underlying shares. I am hereby advised to consult with my own personal tax, legal and financial advisors regarding my participation in the Plan before taking any action related to the Plan.


•	Data Privacy. I hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of my personal data as described in this Award Agreement and any other this option grant materials by and among, as applicable, the Employer and the Corporation for the exclusive purpose of implementing, administering and managing my participation in the Plan.


•	My option may not be assigned, sold, encumbered, or in any way transferred or alienated.


•	If I have received this Award Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.


•	For U.S. Participants only: I acknowledge that the grant of an Award is expressly conditioned on the non-competition provisions set forth in Section 16.


•	The Corporation reserves the right to impose other requirements on my participation in the Plan, on this option and on any shares acquired under the Plan, to the extent that the Corporation determines it is necessary or advisable for legal or administrative reasons, and to require me to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.


•	The Corporation may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. I hereby consent to receive such documents by on-line delivery and agree to participate in the Plan through an on-line or electronic system established and maintained by the Corporation or a third party designated by the Corporation.


•	A waiver by the Corporation of breach of any provision of this Award Agreement shall not operate or be construed as a waiver of any other provision of this Award Agreement, or of any subsequent breach by me or any other employee.


(1)	The Participant’s participation in the Plan does not constitute an acquired right.


(2)	The Plan and the Participant’s participation in the Plan are offered by the Corporation on a wholly discretionary basis.


(4)	Neither the Corporation nor any Affiliate is responsible for any decrease in the value of this option and/or shares of Common Stock acquired under the Plan.


(1)	La participación del Empleado en el Plan no constituye un derecho adquirido.


(2)	El Plan y la participación del Empleado en el Plan se ofrecen por la Compañía de forma completamente discrecional.


(4)	Ni la Compañía ni sus Afiliadas son responsables por la reducción del valor de la opción de Compra de Acciones emitida bajo el Plan.


a)	The Corporation's most recent annual financial statements: http://investor.kimberly-clark.com/sec.cfm?DocType=Annual&Year =


1.	Number of Share Units Granted . The Corporation hereby grants to the Participant the right to receive all or any part of ________ Time-Vested Restricted Stock Units ("RSUs") of the $1.25 par value Common Stock of the Corporation, subject to the terms, conditions and restrictions set forth herein and in the Plan.


(e)	Qualified Termination of Employment . In the event of a Qualified Termination of Employment all restrictions will lapse and the shares will become fully vested and shall be paid within 10 days following the last day of employment of the Participant with the Corporation or an Affiliate.


(f)	Payment of Awards . The payment of the Award shall be made in shares of Common Stock. The payment of an Award shall be made within 70 days following the end of the Restricted Period.


3.	Nontransferability . Neither the Award nor the Participant’s right to receive payment for vested Awards may be assigned or transferred except upon the death of the Participant (i) by will or (ii) by the laws of descent and distribution.


15.	Conflict with Plan . This Award is awarded pursuant to and subject to the Plan. This Agreement is intended to supplement and carry out the terms of the Plan. It is subject to all terms and provisions of the Plan and, in the event of a conflict, the Plan shall prevail.


(3)	withholding shares to be issued upon vesting of the Award.